During the last session, Fractyl Health Inc (NASDAQ:GUTS)’s traded shares were 0.31 million, with the beta value of the company hitting -0.42. At the end of the trading day, the stock’s price was $1.58, reflecting an intraday loss of -4.82% or -$0.08. The 52-week high for the GUTS share is $10.50, that puts it down -564.56 from that peak though still a striking 13.29% gain since the share price plummeted to a 52-week low of $1.37. The company’s market capitalization is $75.99M, and the average intraday trading volume over the past 10 days was 0.45 million shares, and the average trade volume was 345.70K shares over the past three months.
Fractyl Health Inc (GUTS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. GUTS has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.44.
Fractyl Health Inc (NASDAQ:GUTS) trade information
Fractyl Health Inc (GUTS) registered a -4.82% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -4.82% in intraday trading to $1.58, hitting a weekly high. The stock’s 5-day price performance is 4.64%, and it has moved by -13.66% in 30 days. Based on these gigs, the overall price performance for the year is -79.10%. The short interest in Fractyl Health Inc (NASDAQ:GUTS) is 2.4 million shares and it means that shorts have 6.05 day(s) to cover.
Fractyl Health Inc (GUTS) estimates and forecasts
Statistics show that Fractyl Health Inc has outperformed its competitors in share price, compared to the industry in which it operates. Fractyl Health Inc (GUTS) shares have gone down -29.15% during the last six months, with a year-to-date growth rate more than the industry average at 94.98% against 17.50. In the rating firms’ projections, revenue will decrease -16.67% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 10k as predicted by 1 analyst(s).
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -126.07%. While earnings are projected to return 96.46% in 2025, the next five years will return 66.13% per annum.
GUTS Dividends
Fractyl Health Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Also, the Mutual Funds coming in first place with the largest holdings of Fractyl Health Inc (GUTS) shares are iShares Russell 2000 ETF and MFS New Discovery Fund . Data provided on Nov 30, 2024 indicates that iShares Russell 2000 ETF owns about 955.06 shares. This amounts to just over 1.99 percent of the company’s overall shares, with a $1.51 million market value. The same data shows that the other fund manager holds slightly less at 639.15, or about 1.33% of the stock, which is worth about $1.01 million.
